These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6367055)

  • 1. Bone marrow transplantation in acute nonlymphoblastic leukemia.
    Zwaan FE; Jansen J
    Semin Hematol; 1984 Jan; 21(1):36-42. PubMed ID: 6367055
    [No Abstract]   [Full Text] [Related]  

  • 2. Marrow transplantation in patients with acute myeloid leukemia.
    Clift R; Buckner CD; Bianco J; Petersen F; Appelbaum F
    Leukemia; 1992; 6 Suppl 2():104-9. PubMed ID: 1578907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone marrow transplantation after intensive chemotherapy].
    Masaoka T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminishing morbidity and mortality of bone marrow transplantation.
    Tutschka PJ
    Vox Sang; 1986; 51 Suppl 2():87-94. PubMed ID: 3020798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioning regimens for marrow grafting.
    van Bekkum DW
    Semin Hematol; 1984 Apr; 21(2):81-90. PubMed ID: 6377501
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
    Storb R; Deeg HJ; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Doney K; Farewell V
    N Engl J Med; 1986 Mar; 314(12):729-35. PubMed ID: 3513012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW; Tutschka PJ; Brookmeyer R; Saral R; Beschorner WE; Bias WB; Braine HG; Burns WH; Elfenbein GJ; Kaizer H
    N Engl J Med; 1983 Dec; 309(22):1347-53. PubMed ID: 6355849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow transplantation in acute leukemia: results in a series of 51 consecutive patients prepared with cyclophosphamide and total body irradiation].
    Grañena A; Rozman C; Carreras E; Marín P; Hernández-Prieto M; Olivé MT; Nomdedeu B; Montserrat E; Feliu E; Bladé J
    Med Clin (Barc); 1985 Oct; 85(12):479-85. PubMed ID: 3908844
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
    Anderson JE; Appelbaum FR; Schoch G; Gooley T; Anasetti C; Bensinger WI; Bryant E; Buckner CD; Chauncey T; Clift RA
    J Clin Oncol; 1996 Jan; 14(1):220-6. PubMed ID: 8558201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in hematologic malignancies.
    Thomas ED
    Hosp Pract (Off Ed); 1987 Feb; 22(2):77-91. PubMed ID: 3027113
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
    Ringdén O; Ruutu T; Remberger M; Nikoskelainen J; Volin L; Vindeløv L; Parkkali T; Lenhoff S; Sallerfors B; Ljungman P
    Transplant Proc; 1994 Jun; 26(3):1831-2. PubMed ID: 8030160
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of four different protocols for prophylaxis against graft-versus-host disease.
    Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3008-10. PubMed ID: 2650414
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
    Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
    [No Abstract]   [Full Text] [Related]  

  • 16. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of immunosuppression on acute liver toxicity after intensified conditioning regimens for bone marrow transplantation in children.
    Emminger W; Emminger-Schmidmeier W; Peters C; Gadner H
    Blood; 1991 Apr; 77(7):1621. PubMed ID: 1844122
    [No Abstract]   [Full Text] [Related]  

  • 19. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
    Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of bone marrow transplantation for haematological disorders.
    Tricot G; Boogaerts MA; Van der Schueren E; Casteels-Van Daele M; Verwilghen RL
    Acta Clin Belg; 1985; 40(2):75-83. PubMed ID: 3895794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.